0001193125-26-103127
SEC filingAtara Biotherapeutics, Inc. filed an 8-K on March 12, 2026, under Item 8.01 with Exhibit 99.1 being a press release dated March 12, 2026. No specific disclosure content or Item details beyond the filing structure are provided in the document.